ArticlePDF Available

Are inmates' subjective sleep problems associated with borderline personality, psychopathy, and antisocial personality independent of depression and substance dependence?

Authors:

Abstract

Previous research investigating the relationship between Borderline Personality Disorder (BPD) and sleep problems, independent of depression, has been conducted on small atypical samples with mixed results. This study extends the literature by utilizing a much larger sample and by statistically controlling for depression and substance dependence. Subjective reports of sleep problems were obtained from 513 jail inmates (70% male) incarcerated on felony charges. Symptoms of BPD were significantly associated with sleep problems even when controlling for depression. Thus, sleep problems associated with BPD cannot be attributed simply to co-morbid symptoms of depression and substance dependence was ruled out as proximal causes for this relationship. Symptoms of depression, but not Antisocial Personality features, were related to sleep problems independent of substance dependence. Treatment of individuals with BPD may be more effective if sleep problems are explicitly addressed in the treatment plan.
Are inmates’ subjective sleep problems associated with
borderline personality, psychopathy, and antisocial personality
independent of depression and substance dependence?
Laura Harty*, Rebecca Duckworth, Aaron Thompson, Jeffrey Stuewig, and June P. Tangney
Department of Psychology, George Mason University, Fairfax, USA
Abstract
Previous research investigating the relationship between Borderline Personality Disorder (BPD) and
sleep problems, independent of depression, has been conducted on small atypical samples with mixed
results. This study extends the literature by utilizing a much larger sample and by statistically
controlling for depression and substance dependence. Subjective reports of sleep problems were
obtained from 513 jail inmates (70% male) incarcerated on felony charges. Symptoms of BPD were
significantly associated with sleep problems even when controlling for depression. Thus, sleep
problems associated with BPD cannot be attributed simply to co-morbid symptoms of depression
and substance dependence was ruled out as proximal causes for this relationship. Symptoms of
depression, but not Antisocial Personality features, were related to sleep problems independent of
substance dependence. Treatment of individuals with BPD may be more effective if sleep problems
are explicitly addressed in the treatment plan.
Keywords
sleep problems; depression; substance abuse; psychopathy; borderline; personality; anti-social
personality
Borderline Personality Disorder (BPD) is characterized by marked impulsivity and pervasive
instability of affect, self-image, and interpersonal relationships. High rates of substance abuse
(Hatzitaskos, Soldatos, Kokkevi, & Stefanis, 1999; McCann & Ball, 2000), antisocial activity
(Coid, 1993), and behaviors aimed at harming the self (Wilkins & Coid, 1991) or others
(Hernandez-Avila, Burleson, Poling, Tennen, Rounsaville, & Kranzler, 2000) have been
associated with BPD. As a consequence, individuals with BPD are at elevated risk for
involvement in the criminal justice system. Whereas prevalence rates for BPD in the
community are 1–2% (Kraus & Reynolds, 2001), rates among both male and female
incarcerated offenders have been estimated at 23–30% (Jordan, Schlenger, William, Fairbank
& Caddell, 1996; Drapalski, Youman, Stuewig, & Tangney, 2008). In this report, we draw on
data from a larger longitudinal study of jail inmates to examine the implications of BPD for
sleep disturbance, independent of potentially confounding factors such as depression and
substance use. We also extend this literature by considering two other personality disorders
prevalent among inmates – antisocial personality disorder and psychopathy.
*Corresponding author. lhartygmu@gmail.com.
NIH Public Access
Author Manuscript
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
Published in final edited form as:
J Forens Psychiatry Psychol. 2010 February 1; 21(1): 23–39. doi:10.1080/14789940903194095.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Previous Efforts to Disentangle the relationship of BPD and Sleep Problems,
Independent of Depression
There is a well-documented relationship between symptoms of depression and sleep problems
(Mayers & Baldwin, 2006; Rotenberg, Indursky, Kayumov, Sirota, & Melamed, 2000). In
addition, recent research underscores a link between Borderline Personality Disorder (BPD)
and impairment in sleep (Asaad, Okasha, & Okasha, 2002; Maunchnik, Schmahl, & Bohus,
2005). Since symptoms of depression often co-occur with BPD (Southwick, Yehuda, & Giller,
1995; Westin et al., 1992), recent research has examined whether impairments in sleep quality
in patients with BPD can be largely explained by co-morbid depressive symptoms (Asaad et
al., 2002; Battaglia, Strambi, Bertella, Bajo, & Bellodi, 1999; Bell, Lycaki, Jones, Kelwala, &
Sitaram, 1983; Benson, King, Gordon, & Silva, 1990; De la Fuente et al., 2004).
In an attempt to disentangle the effects between symptoms of depression and symptoms of
Borderline Personality Disorder (BPD), several researchers have assessed sleep quality in small
samples of patients diagnosed with BPD who report no symptoms of depression. Battaglia et
al. (1999) observed sleep anomalies in this subgroup of patients (n = 10, 6 women) compared
to healthy, age- and gender-matched controls (n = 10, 6 women). The results revealed that
persons in the non-depressed BPD subgroup had higher levels of REM density (eye movements
per REM period) during the first REM period than did never-depressed, matched controls, but
did not differ in terms of their delta sleep percentages. Philipsen et al. (2005) did not replicate
Battaglia’s finding for REM density. In their study comparing BPD individuals without current
depression (n = 20, all women) with healthy age- and gender-matched controls (n = 20) across
a broad array of objective measures of sleep, no differences were observed except that those
with BPD had less percentage of Stage 2 sleep relative to controls (Philipsen et al., 2005).
Group differences were more pronounced when considering subjective reports of sleep quality.
While in the sleep lab, patients in the BPD group rated themselves as having more sleep related
problems on a number of indicators, including lower sleep quality, than did controls.
Furthermore, in the two weeks prior to being in the lab, patients in the BPD group rated the
efficiency of their sleep (ratio of sleep time to the amount of time in bed) significantly worse
and were significantly poorer at estimating their total sleep time than were the controls.
Asaad et al. (2002) compared objective and subjective measures of sleep quality obtained from
(a) individuals diagnosed as BPD without co-morbid depressive symptoms (n = 20, 12 women),
(b) individuals diagnosed with depressive symptoms without co-morbid BPD (n = 20, 12
women), and (c) healthy, age- and gender-matched controls (n = 20, 12 women). All of the
depression-only group and 45% of the BPD-only group reported significant sleep problems
whereas only 10% of the control participants indicated subjective sleep difficulties. The
researchers also utilized polysomnography equipment to identify where the three groups
differed. Participants with depression only showed significantly more impaired sleep latency
(between when the participant attempts to sleep and when sleep actually occurs), sleep
efficiency and number of arousals than the BPD only and control groups. Sleep latency and
sleep efficiency were also significantly worse in the BPD group compared to the controls but
there was not a significant difference for the number of arousals (Asaad et al., 2002).
Benson et al. (1990) obtained objective measures of sleep from (a) individuals diagnosed with
BPD and a past or present diagnosis of Major Depressive Disorder (MDD) or Bipolar Disorder
(BD; n = 8, all men), (b) individuals diagnosed with BPD without past/present MDD or BD
diagnosis (n = 10, all men), and (c) age and gender matched healthy controls (n = 15, all men).
In contrast to Asaad et al. no differences were found between BPD groups and controls in sleep
latency (Benson et al., 1990). Compared to controls, both BPD groups had less total sleep,
more Stage 1 sleep, and less Stage 4 sleep. Differences in sleep between the two BPD groups,
Harty et al. Page 2
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
however, were not tested. T-tests were thus applied by the present researchers on the data
presented in their article and significant results were not found.
De la Fuente, Bobes, Vizuete, and Mendlewicz (2001) found differences between sleeping
patterns of (a) BPD patients without current depression (n=20, 14 women), (b) non-BPD MDD
patients (n=20, 15 women), and (c) controls (n=20, 14 women) matched on age and gender.
In contrast to Philipsen et al’s generally null findings, De la Fuente et al. found a number of
different objective measures to be significant between BPD and controls. BPD and MDD
groups had less total sleep, longer sleep latency, and more wakefulness than control subjects.
However, BPD patient sleep was characterized by more REM sleep and less Stage 3, Stage 4,
and slow wave sleep as compared to those with MDD and controls (De la Fuente et al.,
2001). Furthermore when subdividing the BPD group, BPD patients with a past history of
MDD (n=9) reported more wakefulness and less slow wave sleep than BPD patients without
such history (n=11). The authors concluded that while participants with BPD and MDD had
similar sleep-continuity, the groups can be distinguished by the architecture of sleep.
De la Fuente et al. (2004) extended this work by adding a group of patients with Recurrent
Brief Depression (RBD; n = 20, 14 women) to the samples compared in De la Fuente, et al.
(2001). BPD patients had greater REM duration and less stage 3 and slow wave sleep than
RBD patients (De la Fuente et al., 2004).
Finally, Bell et al. (1983) compared patients with BPD and MDD (n=15, 10 women) to patients
with MDD but no current or past Borderline features (n=18, 10 women) on sleep quality and
duration, including percent Delta and percent REM sleep. No differences were observed
between the two groups. However, when depressive symptoms were partialled out, one of the
13 dependent variables (REM latency), was statistically significant. BPD-MDD patients
showed shorter REM latency compared to MDD-only patients (Bell et al., 1983).
Taken together, the available evidence suggests that some – but by no means all – of the sleep
difficulties associated with BPD can be explained by comorbid symptoms of depression.
Available research, however, is limited by a reliance on atypical, discrete groups (e.g., “non-
affective” BPD), small sample sizes, or both. A diagnosis of BPD without a history of
depression is unusual, and thus it is not clear whether the results of studies focusing on “non-
affective” BPD groups generalize to the much larger population of individuals with BPD and
co-morbid affective symptoms.
The Current Study
To better assess the degree to which symptoms of BPD are related to sleep difficulties,
independent of affective symptoms, the current study draws on a much larger sample of
individuals in which symptoms of BPD, anxiety and depression were assessed along
continuous dimensions. As such, the study design provides a much more powerful context in
which to evaluate the question: Is the association between sleep problems and symptoms of
BPD largely accounted for by co-occurring symptoms of depression and anxiety? Or is BPD
independently associated with sleep problems, perhaps reflective of more fundamental self-
regulatory difficulties?
If features of Borderline Personality Disorder are related to sleep problems, independent of
depression and anxiety, an alternative explanation remains. Comorbid substance dependence
may account for the sleep problems reported by patients with BPD. Substance abuse and
dependence are common problems among people with BPD (Miller, Abrams, Dulit, & Fyer,
1993; Trull, Sher, Minks-Brown, Durbin, & Burr, 2000) and sleep problems are also linked to
alcohol and drug dependence (Karam-Hage, 2004; Teplin, Raz, & Daiter, 2006). Thus, in the
Harty et al. Page 3
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
current study, we also examine the degree to which the relationship of symptoms of Borderline
Personality Disorder and sleep problems is independent of symptoms of substance abuse.
Finally, we explore the relation of sleep problems to symptoms of two other disorders of
personality – Antisocial Personality Disorder (ASPD) and psychopathy. The research reviewed
thus far has focused on BPD and sleep in clinical and community samples. However, BPD and
substance abuse may frequently co-occur with ASPD and psychopathy. Thus, studies of
correctional samples are especially important to consider. Lindberg et al., (2003) found that
inmates diagnosed with ASPD who had a history of recurrent violent acts with no history of
psychosis, dementia, or major depression (n = 19, all men) also showed disordered sleep
patterns as indicated by objective sleep parameters, relative to controls (n=11, all men).
Philipsen et al. (2005) noted objective measures of sleep disturbance found in their study of
non-depressed, non-incarcerated female BPD participants were similar to that observed the
sample of incarcerated male participants with ASPD in the Lindberg et al. (2003) study.
Psychopathy is a more serious personality disorder than ASPD, characterized by pervasive
antisocial behavior, as well as marked dysfunction in emotional connectedness to others.
(Antisocial Personality Disorder requires just the former, not the latter.) We were able to locate
only one study which investigated the relationship between sleep and psychopathy. Salley et
al. found no evidence of sleep problems associated with psychopathy in prison sample (n=23,
all males, however, the projective method (Rorschach) used to assess psychopathy is of highly
questionable validity (Salley, Khanna, Byrum, & Hutt, 1980). Further research is needed using
a well-validated measure of psychopathy such as the PCL-R (Hare, 1991). Because substance
abuse is common among individuals diagnosed with Antisocial Personality Disorder and
psychopathy (Hemphill, Hart, & Hare, 1994) we also examined whether any observed
relationships between sleep problems and ASPD and psychopathy are independent of substance
dependence.
Where’s the Diagnosis? DSM-IV-TR and the PAI-BOR Scale
The current study assessed borderline personality using the Personality Assessment Inventory
(PAI, Morey, 1991). Research demonstrates that scores on the PAI-BOR scale converge with
clinicians’ diagnoses of borderline personality disorder based on DSM-IV-TR (APA, 2000)
criteria. In a sample of 63 outpatients (BPD base rate .72), a T-score of 65 was deemed optimal,
with .91 sensitivity, .79 specificity, .94 positive predictive power, .73 negative predictive
power, and an overall correct classification rate of .89 vis-à-vis SCID-II diagnoses (Jacobo,
Blais, Baity, and Harley, 2007). Importantly, the concordance between PAI-derived and
clinician-derived classification is equivalent to the concordance between clinicians using DSM
criteria. For example, in a recent study (Critchfield, Levy & Clarkin, 2007), trained clinicians
using the SCID-II agreed 87% of the time on a diagnosis of BPD (base rate .76). Thus, a cut-
score of 65 on PAI-BOR agrees with a clinician-derived SCID-II diagnosis as well as two
independent SCID-II assessments agree with each other.
Although it is possible to dichotomize the PAI-BOR scale into a meaningful diagnostic
variable, several factors argue against doing so. First, the high cost of dichotomizing continuous
variables in terms of statistical power is well known (Cohen, 1983). Second and related, a
dimensional approach allows for less error in estimating the true shared (and unshared) variance
in syndromes of interest, as is the focus here. Third, as discussed by Krueger and Piasecki
(2002), a correlational approach may be ultimately more useful for assessing co-morbidity
because it circumvents the problem of concordance by chance, especially in cases where the
base rates are quite high, as in the current situation. Fourth, there is ample psychometric
evidence that symptoms of borderline personality are meaningfully distributed on a continuum
(Morey, 1991; Clark, 1999); there exists no empirical evidence arguing in favor of an
Harty et al. Page 4
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
underlying taxon. Thus, for the purposes of the current study we elected not to dichotomize
the PAI-BOR scale, but rather to capitalize on the more complete information inherent in the
continuous measure.
Clinical Relevance of Subjective Experience of Sleep Problems
The current study focused on subjective or felt distress associated with sleep problems. It is
well known that, in many domains of medicine, patients’ subjective experiences do not map
on to physiological realities in a one-to-one fashion. Subjectively experienced pain is only
moderately correlated with objective indicators of injury or pathology. When considering
patients’ functional adaptation to the demands of daily life, it is often the subjective experience,
not the objective physical reality, that is most predictive of key outcomes. For example, in the
domain of social support, subjective perceptions are most consistently and substantially linked
to psychological and social adjustment. Objectively assessed dimensions of social support
account for very little variance (Lakey, 2007). To date, most studies of sleep and BPD have
focused on objective indicators of sleep in atypical patient samples, occasionally including
subjective measures of sleep as a secondary consideration. However, if the focus is on
identifying new targets for intervention in areas causing distress to those with BPD, subjective
measures are of special relevance.
Methods
Participants
Study participants were 513 pre- and post-trial inmates in a metropolitan area county jail. The
targeted population was inmates who would serve at least 4 months in jail. Selection criteria
were (1) either (a) sentenced to a term of 4 months or more, or (b) arrested and held on at least
one felony charge other than probation violation, with no bond or greater than $7,000 bond,
(2) assigned to the jail’s medium and maximum security “general population” (e.g., not in
solitary confinement, not in a separate forensics unit for actively psychotic inmates), and (3)
sufficient language proficiency to complete study protocols in English or Spanish. Of the 603
participants who agreed to participate, 85% (N=513) remained at the jail long enough to
complete portions of the 4–6-session initial assessment relevant to the behaviors reported here.
Participants were on average 32 years old (SD = 10), mostly men (70%), and diverse in terms
of racial/ethnic composition: 35.9% Caucasian, 45% African American, 9% Latina/o, 2.9%
Asian, 0.8% Middle Eastern, 0.4% Native American, and 6% “Other” or “Mixed.”
Procedures
Shortly after their move to the jail’s “general population” (about 1–2 weeks), eligible inmates
were presented with a description of the study and asked to participate. It was emphasized that
the decision to participate or not would have no bearing on their status at the jail or their release
date. Interviews were conducted in the privacy of professional visiting rooms and the data are
protected by a Certificate of Confidentiality from Department of Health and Human Services.
Inmates who completed the 4–6 session intake assessment received a $15–18 honorarium, an
amount deemed non-coercive based on interviews with knowledgeable informants (i.e.,
inmates and deputies) familiar with the economy of this particular correctional setting.
Participants with sufficient English skills completed questionnaires using “touch-screen”
computers that presented items visually and aurally. For participants requiring Spanish versions
of the measures (less than 5% of male participants), questionnaire responses were gathered via
individual interview. Both the interviewer and participant had paper copies of the translated
measures; however to approximate the level of privacy afforded by the touch-screens,
participants filled in their own responses.
Harty et al. Page 5
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Measures
Borderline Personality, Antisocial Personality, Depression, and portions of a Sleep Problems
Index were assessed with the Personality Assessment Inventory (PAI) (Morey, 1991) a 344
item self-report measure of clinically relevant psychopathology and personality traits. The PAI
includes 13 clinical syndrome scales, many of which include subscales reflecting the
multidimensional structure of most psychological disorders. In the current study, internal
consistency estimates of reliability were acceptable, and consistent with those reported by
Morey (Morey, 1991).
Borderline Personality—The Borderline Features total scale of the PAI comprises four
subscales each comprised of six items: Affective Instability, assessing the intense and largely
unmodulated emotional experiences with an emphasis on anger; Identity Problems, assessing
confusion about self-identity and lack of an integrated concept of self and others; Negative
Relationships, reflecting ambivalence about interpersonal relationships, characterized by acute
dependence, fear of abandonment, and distrust; and Self-Harm, ostensibly reflecting self-
harming behaviors that are characteristic of individuals with BPD, however most items assess
the more general characteristic of impulsivity also a hallmark of BPD. Internal reliability of
the total Borderline scale was high (α = .89) while the subscales were acceptable (α = 64 to .
77; mean α = .73). Overall, 31% of the sample obtained T-scores of 70 or above on the total
Borderline scale, the cut score deemed as clinically significant by Morey (1991); 45.5%
obtained T-scores of 65 or above, the cut score identified as optimal by Jacobo, et al, (2007).
Antisocial Personality—The Antisocial Features scale (ANT) (α = .85) of the PAI includes
the subscales of Antisocial Behaviors, Egocentricity, and Stimulus-Seeking. Each subscale
contained eight items and the internal reliability of the subscales were acceptable (α = .70, .
66, .74).
Depression—Three depression subscales from the PAI were used as control variables for
the analyses. The first measures cognitive aspects (8 items, α = .77); the second measures
affective features of depression (8 items, α = .79); and the third taps physiological symptoms
of depression. For the purposes of this study, we considered here only items that do not refer
to sleep problems (4 items, α = .56).
The Psychopathy Checklist-Screening Version—(PCL:SV) (Hart, Cox, & Hare,
1995) is a clinical rating instrument used to assess psychopathy. Like the PCL-R (Hare,
1991), the PCL:SV provides a total psychopathy score as well as two factor scores. Factor 1
captures the personality characteristics associated with psychopathy, including superficiality,
grandiosity, deceitfulness, lack of remorse, lack of empathy, and lack of responsibility. Factor
2 captures the behaviors associated with psychopathy, such as impulsivity, poor behavioral
controls, lack of goals, irresponsibility, adolescent antisocial behavior, and adult antisocial
behavior. Single measure intraclass correlations, using a one-way random effects model, were .
85, .88, and .87 for Factor 1, Factor 2, and Total PCL:SV scores, respectively, showing a high
degree of interrater reliability.
Drug and alcohol dependence—Drug and alcohol dependency symptoms were assessed
using Simpson and Knight’s (Simpson & Knight, 1998) Texas Christian University
Correctional: Residential Treatment Form, Initial Assessment (TCU-CRTF). Specifically, four
scales were created to assess symptoms of dependency on alcohol, marijuana, cocaine, and
opiates in the year prior to incarceration. Each scale was composed of items that assess each
of the DSM-IV (APA, 2000) substance dependence domains (e.g., for the domain of tolerance
participants answered the question “How often did you find that your usual number of drinks
had much less effect on you or that you had to drink more in order to get the effect you
Harty et al. Page 6
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
wanted?”). For domains with multiple items, responses were averaged and a total score was
computed by taking the mean across the domains (α = .92 to .98).
Sleep Problems—A five-item index of sleep problems was created comprising four items
from the PAI’s physiological subscale of depression that deal explicitly with sleep problems
(I have no trouble falling asleep (reversed), I rarely have trouble sleeping (reversed), I often
wake up very early in the morning and can't get back to sleep, I often wake up in the middle
of the night) and one item from the Cohen-Hoberman Inventory of Physical Symptoms
(CHIPS; Cohen & Hoberman, 1983) (How much were you bothered by sleep problems [for
instance, can't fall asleep, wake up in the middle of night or early in the morning]?). The
individual items were standardized and then averaged. Reliability of the 5 item index was good
(α = .79). Inspection of the items indicates strong face validity and, regarding content validity,
the range of content is very similar to other widely used self report measures of sleep problems.
An exploratory factor analysis extracted one factor verifying that the scale yields a
unidimensional index of subjective sleep problems, similar to the widely used three-and four-
item sleep problem scales developed by Jenkins, Stanton, Niemcryk & Rose (1988). Other,
longer self-report measures of sleep problems exist, but with few exceptions the researchers
in the field focus on subjectively experienced sleep problems as a unidimensional construct.
Results
Pearson’s bivariate correlations were conducted to determine the extent to which subjective
sleep problems were associated with symptoms of BPD, antisocial personality disorder,
psychopathy, depression, and substance dependence (See Table 1). Consistent with previous
studies there was a significant positive correlation between sleep problems and BPD.
Furthermore, all four BPD subscales -- Affective Instability, Identity Problems, Negative
Relationships, and Self Harm (assessing primarily impulsivity) -- were related to sleep
problems. Positive correlations were also found between sleep problems and antisocial and
stimulus seeking features of antisocial personality, Factor 2 psychopathy, cognitive, affective,
and (minus sleep problem items) physiological depression, and symptoms of alcohol, cocaine
and opiate dependence specifically (see Table 1).
When indices of cognitive, affective, and physiological depression (not including sleep items)
were partialled out, the correlation between BPD and sleep problems remained significant.
Symptoms of BPD were associated with poor sleep, above and beyond the influence of any
co-morbid depressive symptoms. In contrast, the association between sleep problems and most
other personality and behavioral problems (antisocial behavior, sensation-seeking,
psychopathy, alcohol and cocaine dependence) did not hold once depression was partialled
out. Only opiate dependence showed a unique relationship to sleep problems, beyond
depression.
Next, we examined the degree to which the association between sleep problems and personality
and behavioral problems could be attributed to co-morbid substance dependence. The right-
most column of Table 1 presents the relationship of psychological measures to sleep problems,
partialling out alcohol, marijuana, cocaine, and opiate dependence. When controlling for
substance dependence, sleep problems remained significantly associated with BPD and
depression. The link between sleep problems and features of antisocial personality and Factor
2 psychopathy appears largely due to substance dependence, depression, or both.
Discussion
In the present study of 513 jail inmates, BPD and its four subscales (identity problems, negative
relationships, self-harm and affective instability) were significantly associated with the
Harty et al. Page 7
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
subjective experience of sleep problems. Further, the relationship between subjective sleep
problems and the BPD total scale as well as the subscales remained significant when controlling
for co-morbid depression, assessed in detail along three sub-dimensions (affective, cognitive,
and physiological). These results indicate that symptoms of BPD are uniquely associated with
sleep problems above and beyond the effect of depression, which itself is associated with sleep
difficulties. In short, the sleep problems associated with BPD cannot be attributed simply to
co-morbid symptoms of depression.
The current results also speak to the question of whether subjective sleep problems experienced
by individuals with BPD may be due to co-morbid substance dependence. Although substance
use is common among individuals with BPD (Miller et al., 1993; Trull et al., 2000) and also
can exacerbate sleep problems, to our knowledge no previous studies have taken into account
chronic substance use or dependence when examining the link between BPD and sleep
problems.1 In the current study, a detailed assessment of participants’ recent history of
substance use and symptoms of dependency was conducted. Analyses indicated that the link
between BPD and sleep problems was independent of the effects of substance dependence.
Sleep problems appear to be uniquely related to symptoms of BPD.
In contrast, although sleep problems were associated with features of antisocial personality,
Factor 2 psychopathy (antisocial lifestyle), and alcohol, and cocaine dependence at the bivariate
level, these findings did not remain significant when depression was partialled out. In other
words, depression accounted for these correlations, suggesting that co-morbid symptoms of
depression were primarily responsible for the sleep problems associated with these personality
and behavioral factors. Only the relationship between opiate dependence and sleep problems
remained significant after controlling for depression. Opiate dependence appears to have a
unique relationship with sleep problems above and beyond the effects of depression.
Previous research investigating the relationship between BPD and sleep problems, independent
of depression, have been conducted on small, atypical samples of individuals with BPD (e.g.,
patients with BPD but with no history of depression) and have yielded mixed results. The low
statistical power of previous studies precludes interpretation of null findings, and the use of
atypical patient samples seriously limits the ability to generalize results to the larger BPD
population. The present study circumvented limitations of the previous research by obtaining
data from a much larger sample and by statistically controlling for the effects of depression,
rather than attempting to segregate the sample into discrete clinical groups. In addition, this
study extends the empirical research on sleep problems associated with BPD by ruling out
substance dependence as a proximal cause for this relationship.
Clinical Implications
People with BPD are particularly vulnerable to sleep difficulties, above and beyond what would
be expected due to co-occurring depression (or substance abuse problems). Thus, mental health
professionals working with individuals with BPD should routinely assess the degree to which
such clients are experiencing difficulties with sleep. Given that sleep problems have been found
to significantly increase the risk for aggression (Ireland & Culpin, 2006), depression (Kupfer,
2006; Perlis et al., 2006; Perlman, Johnson, & Mellman, 2006; Roman, Hagewoud, Luiten, &
Meerlo, 2006) and other psychiatric illnesses (Hajak et al., 2003) treatment of individuals with
BPD may be more effective if sleep problems are explicitly addressed in the treatment plan.
There are a range of effective behavioral and psychopharmacological interventions for
ameliorating this source of stress and distress.
1De la Fuente, et al.’s (2001, 2004) study included a “drug washout period,” but individual differences in substance abuse were not
considered.
Harty et al. Page 8
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
In addition, these results may provide clues for basic research on the biopsychosocial bases of
BPD. Although sleep problems are associated with a range of psychological problems, most
can be explained by co-morbid symptoms of depression. BPD stands out as having a special,
independent link with sleep problems. It is possible that the problems with sleep regulation
experienced by individuals with BPD are reflective of a more general impairment in self-
regulation. A common biological substrate may account for both BPD-related sleep problems
and for the severe impairment in psychological self-regulation that is the hallmark of BPD.
Limitations and Directions for Future Research
Although the current study adds substantially to the literature on sleep problems among
individuals with BPD, the research is not without limitations. First, this study relied on self-
reports for many of the measures. Nonetheless, research suggests that the Personality
Assessment Inventory has a high concordance with clinical diagnoses (Jacobo, et al., 2007).
And although research has documented a clear relationship between subjective and objective
measures of sleep (Carlson, Karlson, Hamilton, Nelson, & Luxton, 2006) the two types of
measures are by no means synonymous. Moreover, Philipsen et al. (2005) found that
discrepancies between subjective and objective measures of sleep quality were, if anything,
more pronounced among individuals with BPD, relative to asymptomatic controls. Future
research, employing polysomnography recordings would provide a more detailed picture of
the physiological patterns associated with perceived sleep problems as experienced by
individuals with BPD.
Second, the current study used a dimensional measure of borderline personality disorder; thus
it was not possible to examine definitive diagnoses at the individual level. Although
dimensional assessments are most consistent with the actual distribution of patient
characteristics and offer greater statistical precision than diagnostic dichotomies, future work
also employing clinician-rated diagnostic measures would be useful.
Third, borderline personality disorder is often comorbid with other mental health problems that
may influence sleep disturbances. While data on the symptoms of depression and substance
dependence were gathered in this study, symptoms of other disorders that influence sleep
problems such as attention-deficit/ hyperactivity disorder and post-traumatic stress disorder
were not collected. This would be a useful direction for future research.
Finally, additional research is necessary to determine whether these findings apply to
individuals in noncorrectional settings. The sample used in the current study was drawn from
a jail inmate population, rather than a more traditional clinical setting. It’s worth noting,
however, that jail inmates do not represent a particularly atypical subgroup of individuals with
BPD. Deinstitutionalization of the mentally ill has led to a dramatic increase in incarceration
rates over the past few decades. In the current study, 77% of participants scored in the clinical
range on at least one of the PAI clinical scales (Drapalski, et al., 2008), a figure consistent with
other studies employing clinician-based diagnostic assessments (Teplin, Abram, &
McClelland, 1996; Teplin et al., 2006). The prevalence of BPD is astoundingly high and gender
neutral in correctional settings (Jordan, Schlenger, Fairbank, & Caddell, 1996; Tangney,
Stuewig, Hastings, & Hashemi, 2004). Thus, jail inmates represent a large, woefully
unrecognized, understudied and underserved subgroup of individuals with BPD. Recognizing
and examining how BPD and sleep problems may co-occur above and beyond other symptoms
of psychopathology may help us gain insight into new ways to intervene and treat this
debilitating disorder.
Harty et al. Page 9
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
References
APA, editor. Diagnostic and statistical manual of mental disorders. 4th ed-text revision. Washington,
D.C: American Psychiatric Association; 2000.
Asaad T, Okasha T, Okasha A. Sleep EEG findings in ICD-10 borderline personality disorder in Egypt.
Journal of Affective Disorders 2002;71:11–18. [PubMed: 12167496]
Battaglia M, Strambi LF, Bertella S, Bajo S, Bellodi L. First-cycle REM density in never-depressed
subjects with borderline personality disorder. Society of Biological Psychiatry 1999;45:1056–1058.
Bell J, Lycaki H, Jones D, Kelwala S, Sitaram N. Effect of preexisting borderline personality disorder
on clinical and EEG sleep correlates of depression. Psychiatry Research 1983;9:115–123. [PubMed:
6578523]
Benson KL, King R, Gordon D, Silva JA. Sleep patterns in borderline personality disorder. Journal of
Affective Disorders 1990;18:267–273. [PubMed: 2140379]
Carlson, J.; Karlson, C.; Hamilton, N.; Nelson, C.; Luxton, D. Relationship between subjective and
objective measures of sleep duration and sleep efficiency; Paper presented at the Poster presented at
the meetings of the American Psychological Association; New Orleans, LA. 2006 Aug.
Clark, LA. Dimensional approaches to personality disorder assessment and diagnosis. In: Cloninger, CR.,
editor. Personality and psychopathology. Washington, D. C: American Psychiatric Press; 1999. p.
219-244.
Cohen J. The cost of dichotomization. Applied Psychological Measurement 1983;7:249–253.
Cohen S, Hoberman HM. Positive events and social support as buffers of life change stress. Journal of
Applied Social Psychology 1983;13:99–125.
Coid JW. An affective syndrome in psychopaths with Borderline Personality Disorder? British Journal
of Psychiatry 1993;162:641–650. [PubMed: 8149116]
Critchfield KL, Levy KN, Clarkin JF. The Personality Disorders Institute/Borderline Personality Disorder
Research Foundation randomized control trial for Borderline Personality Disorder: Reliability of axis
I and II diagnoses. Psychiatric Quarterly 2007;78:15–24. [PubMed: 17102935]
De la Fuente JM, Bobes J, Morlan I, Bascaran MT, Vizuete C, Linkowski P, et al. Is the biological nature
of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic?
Sleep EEG comparison with recurrent brief, major depression and control subjects. Psychiatry
Research 2004;129:65–73. [PubMed: 15572186]
De la Fuente JM, Bobes J, Vizuete C, Mendlewicz J. Sleep-EEG in borderline patients without
concomitant major depression: A comparison with major depressives and normal control subjects.
Psychiatry Research 2001;105:87–95. [PubMed: 11740978]
Drapalski A, Youman K, Stuewig J, Tangney JP. Gender differences in jail inmates’ symptoms of mental
illness, treatment history and treatment seeking. 2008 Manuscript under review.
Hajak G, Cluydts R, Allain H, Estivill E, Parrino L, Terzano MG, et al. The challenge of chronic insomnia:
is non-nightly hypnotic treatment a feasible alternative? European Psychiatry 2003;18(5):201–208.
[PubMed: 12927320]
Hare, RD. The Hare Psychopathy Checklist-Revised. Toronto: Multi-Health Systems; 1991.
Hart, SD.; Cox, D.; Hare, RD. Manual for the Psychopathy Checklist: Screening Version (PCL:SV).
Toronto: Multi-Health Systems; 1995.
Hatzitaskos P, Soldatos CR, Kokkevi A, Stefanis CN. Substance abuse patterns and their association with
psychopathology and type of hostility in make patients with BPD and ASPD. Comprehensive
Psychiatry 1999;40(4):278–282. [PubMed: 10428187]
Hemphill JF, Hart SD, Hare RD. Psychopathy and substance use. Journal of Personality Disorders
1994;8:169–180.
Hernandez-Avilia C, Burleson JA, Poling J, Tennen H, Rounsaville BJ, Kranzler HR. Personality and
substance use disorders as predictors of criminality. Comprehensive Psychiatry 2000;41(4):276–283.
[PubMed: 10929796]
Ireland JL, Cupin V. The relationship between sleeping problems and aggression, anger, and impulsivity
in a population of juvenile and young offenders. Journal of Adolescent Health 2006;38:649–655.
[PubMed: 16730591]
Harty et al. Page 10
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Jacobo MC, Blais MA, Baity MR, Harley R. Concurrent validity of the Personality Assessment Inventory
Borderline scales in patients seeking Dialectical Behavior Therapy. Journal of Personality
Assessment 2007;88:74–80. [PubMed: 17266417]
Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM. A scale for the estimation of sleep problems in clinical
research. Journal of Clinical Epidemiology 1988;41:313–321. [PubMed: 3351539]
Jordan KB, Schlenger WE, Fairbank JA, Caddell JM. Prevalence of psychiatric disorders among
incarcerated women: II. Convicted felons entering prison. Archives of General Psychiatry 1996;53
(6):513–519. [PubMed: 8639034]
Karam-Hage M. Treating insomnia in patients with substance use/abuse disorders. Psychiatric Times
2004;21:1–7.
Kraus G, Reynold DJ. The “A-B-C’s” of the Cluster B’s: Identifying, understanding, and treating Cluster
B personality disorders. Clinical Psychology Review 2001;21(3):345–373. [PubMed: 11288605]
Krueger RF, Piasecki TM. Toward a dimensional and psychometrically-informed approach to
conceptualizing psychopathology. Behaviour Research and Therapy 2002;40:485–499. [PubMed:
12038642]
Kupfer DJ. Depression and associated sleep disturbances: patients benefit with agomelatine. European
Neuropsychopharmacology 2006;15:S639–S643.
Lakey, B. Social support. In: Maddux, JE.; Tangney, JP., editors. Social Psychological Foundations of
Clinical Psychology. New York: Guilford Press; 2007. (In preparation.)
Lindberg N, Tani P, Appelberg B, Sternberg D, Naukkarinen H, Rimon R, et al. Sleep among habitually
violent offenders with antisocial personality disorder. Neuropsychobiology 2003;47:198–205.
[PubMed: 12824743]
Maunchnik J, Schmahl C, Bohus M. New findings in the biology of borderline personality disorder.
Directions in Psychiatry 2005;25:197–215.
Mayers AG, Baldwin DS. The relationship between sleep disturbances and depression. International
Journal of Psychiatry in Clinical Practice 2006;10:2–16.
McCann RA, Ball EM. DBT with an inpatient forensic population: The CMHIP Forensic Model.
Cognitive and Behavioral Practice 2000;7:447–456.
Miller FT, Abrams T, Dulit R, Fyer M. Substance abuse in borderline personality disorder. American
Journal of Drug and Alcohol Abuse 1993;19:491–497. [PubMed: 8273769]
Morey, LC. The Personality Assessment Inventory Professional Manual. Odessa, FL: Psychological
Assessment Resources; 1991.
Perlis ML, Smith LJ, Lyness JM, Matteson SR, Pigeon WR, Jungquist CR, et al. Insomnia as a risk factor
for onset of depression in the elderly. Behavioral Sleep Medicine 2006;4(2):104–113. [PubMed:
16579719]
Perlman CA, Johnson SL, Mellman TA. The prospective impact of sleep duration on depression and
mania. Bipolar Disorders 2006;8(3):271–274. [PubMed: 16696829]
Philipsen A, Feige B, Al-Shajlawi A, Schmahl C, Bohus M, Richter H, et al. Increased delta power and
discrepancies in objective and subjective sleep measures in borderline personality disorder. Journal
of Psychiatric Research 2005;39:489–498. [PubMed: 15992558]
Roman V, Hagewoud R, Luiten PGM, Meerlo P. Differential effects of chronic partial sleep deprivation
and stress on serotinin-1A and muscarinic acetylcholine receptor sensitivity. Journal of Sleep
Research 2006;15:386–394. [PubMed: 17118095]
Rotenberg VS, Indursky P, Kayumov L, Sirota P, Melamed Y. The relationship between subjective sleep
estimation and objective sleep variables in depressed patients. International Journal of
Psychophysiology 2000;37:291–297. [PubMed: 10858574]
Salley RD, Khanna P, Byrum W, Hutt LD. REM sleep and EEG abnormalities in criminal psychopaths.
Perceptual and Motor Skills 1980;51:715–722. [PubMed: 7208215]
Simpson, DD.; Knight, K. TCU data collection forms for correctional residential treatment. 1998
[Retrieved August 3, 2006]. from http://www.ibr.tcu.edu
Southwick SM, Yehuda R, Giller EL. Psychological dimensions of depression in borderline personality
disorder. American Journal of Psychiatry 1995;152:789–791. [PubMed: 7726321]
Harty et al. Page 11
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Tangney, JP.; Stuewig, J.; Hastings, M.; Hashemi, N. Borderline personality disorder is more prevalent
than psychopathy among incarcerated offenders; Poster presented at the annual meetings of the
American Society of Criminology; 2004.
Teplin LA, Abram KM, McClelland GM. Prevalence of psychiatric disorders among incarcerated women:
I. Pretrial jail detainees. Archives of General Psychiatry 1996;53(6):505–512. [PubMed: 8639033]
Teplin LA, Raz B, Daiter J. Screening for substance use patterns among patients referred for a variety of
sleep complaints. American Journal of Drug and Alcohol Abuse 2006;32:111–120. [PubMed:
16450646]
Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use
disorders: A review and integration. Clinical Psychology Review 2000;20:235–253. [PubMed:
10721499]
Westin D, Moses MJ, Silk NR, Lohr NE, Cohen R, Segal H. Quality of depressive experience in borderline
personality disorder and major depression: When depression is not just depression. Journal of
Personality Disorders 1992;6:382–393.
Wilkins J, Coid JW. Self-mutilation in female remanded prisoners I: an indicator of severe
psychopathology. Criminal Behavior and Mental Health 1991;1:247–267.
Harty et al. Page 12
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Harty et al. Page 13
Table 1
Relationship of sleep problems to personality disorders.
Bivariate
correlations Partial correlations
Cognitive, affective, &
physiological
depression removed
Substance
dependence
removed
Borderline personality – total scale .43** .20** .39**
Affective instability .32** .10*.29**
Identity problems .41** .16** .37**
Negative relationships .36** .19** .32**
Self-harm .30** .14** .24**
Antisocial personality – total scale .14** .00 .06
Antisocial behaviors .15** .05 .06
Egocentricity .08 .05 .03
Stimulus seeking .13*.00 .06
PCL-SV – Psychopathy total .06 .06 .01
Factor 1 - Psychopathic personality .02 .03 .04
Factor 2 – Antisocial lifestyle .12** .07 .06
Cognitive depression .39** --- .36**
Affective depression .42** --- .39**
Physiological depression .42** --- .40**
Alcohol dependence symptoms .14** .04 ---
Marijuana dependence symptoms .07 .00 ---
Cocaine dependence symptoms .11*.05 ---
Opiate dependence symptoms .21** .17** ---
Note: N = 498--512 (N = 467 for psychopathy).
*p<.05;
**p<.01.
J Forens Psychiatry Psychol. Author manuscript; available in PMC 2011 February 1.
... Yet, inconsistent results within this set of studies make it difficult to articulate clear conclusions regarding the relationship of BPD and individual sleep parameters (Hafizi, 2013;Oltmanns & Oltmanns, 2015;Winsper et al., 2017). These discrepancies could potentially be attributed to the fact that previous related research has been methodologically diverse and conducted in small samples of phenotypically heterogenous groups of individuals with BPD (Harty et al., 2010;Winsper et al., 2017). ...
... In addition, poor sleep and greater suicidal ideation tended to characterize individuals higher in BPD severity rather than poor sleep exacerbating suicidal ideation and negative emotions in BPD patient populations. It is possible that the pattern of results reported in this study reflects more general self-regulatory impairments in BPD that have the potential to spill over into disturbed nightly sleep (Harty et al., 2010;Selby, 2013) that may largely coincide, though not specifically contribute to the exacerbation of suicidal crises in BPD. ...
Article
Full-text available
Sleep disturbance is associated with elevated suicidal ideation and negative affect. To date, however, no study has investigated the temporal relationship between sleep and suicidality among those diagnosed with borderline personality disorder (BPD). This preregistered (https://osf.io/4vugk) study tested whether nightly sleep (self-reported sleep duration, sleep onset latency, and subjective sleep quality) represents a (within-person) short-term risk factor for affective dysregulation and increases in suicide risk from day-to-day, as well as whether between-person differences in sleep, negative affect, and suicidality were associated. We used a 21-day ecological momentary assessment protocol in a sample of 153 people diagnosed with BPD, 105 of which had a history of serious suicide attempts, and 52 healthy controls (N = 4076 days). We found a within-person association between worse subjective sleep quality and greater next-day negative affect. At the between-person level, we found positive relationships between sleep latency and suicidal ideation, and a negative association between subjective sleep quality and negative affect. BPD severity did not significantly moderate the strength of any within-person associations, although BPD was positively associated with average levels of suicidal ideation, sleep latency, and negative affect, and negatively related to subjective sleep quality. These findings suggest that the association of sleep with suicidal ideation and BPD exists largely at the between-persons rather than the within-person level. Disturbed sleep, therefore, seems to largely coincide, rather than specifically contribute to, the exacerbation of suicidal crises in BPD. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
... 66 Sleep disturbances specific to PD were previously reported in the literature, and a study found that sleep disturbances are mediated by the presence of PD, even while controlling for substance dependence and depression. 67 Polysomnographic (PSG) studies also point toward neurobiological differences between TRD/PD+ and TRD/PD−. De la Fuente et al 68 showed sleep architecture differences between patients with MDD (PD−) and PD (MDD−), including increased rapid eye movement and decreased slow wave sleep in the PD compared with the MDD group. ...
Article
Purpose/Background Quetiapine is a first-line augmenting agent for treatment-resistant depression (TRD) and is used off-label in insomnia. Quetiapine and its active metabolite norquetiapine act mostly on 5-HT 2A , 5-HT 2C , H 1 , and D 2 as antagonists and on 5-HT 1A as partial agonists. Patients with TRD often have comorbid personality disorder (PD), and evidence suggests an association between sleep disturbance and recovery among patients with PD. Here, we aimed to evaluate the effects of quetiapine on sleep in TRD patients with and without PD (PD+/PD−). Methods/Procedures We reviewed health records of 38 patients with TRD (20 TRD/PD+) who had been treated with a pharmacotherapy regimen including quetiapine. Clinical outcomes were determined by comparing changes in sleep items of the Hamilton Depression Rating Scale at the beginning (T0) and after 3 months of an unchanged treatment (T3). Findings/Results Patients with TRD/PD+ and TRD/PD− taking quetiapine showed significant improvement in sleep items from T0 to T3 ( P < 0.001, η p ² ≥ 0.19). There was a significant personality × time interaction for sleep-maintenance insomnia ( P = 0.006, η p ² = 0.23), with TRD/PD+ showing a greater improvement at T3 compared with TRD/PD− ( P = 0.01). While exploring other sleep items, no personality × time interaction was found. In the TRD/PD− group, improvement in sleep items was associated with an overall improvement in depressive symptoms ( r = 0.55, P = 0.02). Implications/Conclusions Quetiapine induced greater improvements in sleep-maintenance insomnia among TRD/PD+ patients than TRD/PD−. These findings suggest quetiapine could have a therapeutic role for insomnia in PD underscoring a distinct underlying neurobiological mechanism of sleep disturbance in people living with PD.
... Recent evidence syntheses have identified worse aspects of sleep quality in people with PD compared with people without PD, which include greater pre-sleep hyperarousal, a longer sleeponset latency (SOL), a greater number of post-sleep-onset wakings, and poorer sleep efficiency (Winsper et al., 2017). Moreover, sleep disturbance in this group of people appears independent of cooccurring PTSD (Schredl et al., 2012), depressive symptoms, or substance misuse (Harty et al., 2010). ...
Article
Full-text available
Poor quality sleep is common for people who have a diagnosis of personality disorder (PD). Core cognitive and behavioral features of PD may cause and perpetuate poor sleep, but to date, no review has collated the evidence on the efficacy of interventions to improve sleep quality for people with PD. Structured searches for interventional studies among adults with PD and reporting validated measures of sleep quality were conducted up to November 2022 in multiple databases. Single-case reports were excluded. Study quality was assessed with standardized risk of bias tools. Unreported data was sought systematically from authors. This review was pre-registered with an international prospective register of systematic reviews (PROSPERO) (CRD42021282105). Of the 3503 identified studies, nine met inclusion criteria, representing a range of psychological, pharmaceutical, and other interventions and outcome measures. Meta-analytic methods were not feasible because of the serious risk of bias in all studies, and results were therefore synthesized narratively. There is limited and low-quality evidence of the effects of a variety of interventions to improve the sleep quality of people living with PD. Further research might consider specifically including people diagnosed with PD in trials of sleep interventions and using sleep outcome measures in trials of established PD treatments.
... Self-control was evaluated using the frequently-used 13-item Brief Self-Control Scale (Tangney, Baumeister, & Boone, 2004). Acceptable reliability and validity have been reported (Pechorro, DeLisi, Goncalves, Quintas, & Hugo Palma, n.d.;Harty, Forkner, Thompson, Stuewig, & Tangney, 2010;Tangney et al., 2004). ...
Article
The Cognitive, Affective and Somatic Empathy Scales (CASES) assess three forms of empathy, each with subscales for positive and negative empathy. The present study extends this child instrument to adults and examines its factor structure and construct validity. A secondary aim is to investigate the under-researched area of positive empathy. Community samples totaling 2604 adults completed the CASES for adults, together with scales assessing construct validity. Confirmatory factor analysis supported the three-factor cognitive-affective-somatic model and a two-factor positive-negative empathy model. Findings were replicated in a second independent sample. Internal reliabilities ranged from 0.80 to 0.92. Individuals with higher psychopathy and stimulation-seeking scores were less impaired in their empathic reactions to positive relative to negative valence events, suggesting that they are relatively capable of responding emotionally to rewarding events. Somatic empathy was most strongly associated with pleasure in affective touch and with female > male gender differences in empathy. While proactive aggression was associated with reduced cognitive and affective empathy, reactive aggression was associated with increased empathy. Findings provide initial support for the utility of CASES for assessing different forms of empathy and suggest that the balance between positive and negative empathy could provide new insights into psychological traits.
Article
Objectives: This study aims to determine how the dream themes of borderline personality disorder patients differ from those of without borderline personality disorder diagnosis and the mediating role of rejection sensitivity in this differentiation process. Methods: The convenience sampling method was used in the study, and the participants were 79 female borderline patients diagnosed with semi-structured interviews with criteria of DSM-5 and 79 female individuals who had not received a psychological diagnosis before and at the study interviews. Sociodemographic Information Form, Dream Themes Scale, Borderline Personality Questionnaire, and Rejection Sensitivity Scale were used in the study. Linear Regression Analysis, Hierarchical Regression Analysis, and Independent Groups T-Test were used during the investigations. Results: Borderline personality disorder patients scored higher in all sub-dimensions of the dream themes scale and rejection sensitivity scale than the control group. Borderline personality traits predicted rejection sensitivity. Borderline personality traits and rejection sensitivity together predicted dream themes. Borderline personality predicts anxiety dreams, fear dreams, and experience dreams, and rejection sensitivity mediates these predictive relationships. Conclusions: The dreams of borderline personality disorder patients have negative content covered by the impact of experiences sub-dimension on dream themes, as they contain reflections of negative content in beliefs, thoughts and emotions related to their daily lives. Rejection sensitivity plays a mediator role in borderline patient’s dreams. The study results show that it would be beneficial not to ignore the content of dreams in patients with borderline personality disorder, considering the relationship of negative dreams with daily functioning, dissociative symptoms, self-harming behaviors, and suicide attempts. Results also indicate that it might be beneficial to target rejection sensitivity to reduce aggravating dream contents.
Article
Background: Borderline personality disorder (BPD) patients commonly suffer from nightmares. Still, the prevalence of this issue does not match the little clinical attention it usually receives. Nightmares impact sleep and daily functioning and may play a role in BPD symptomatology, including suicidality. Since BPD has been linked with high rates of suicide, the potential connection with suicidality is crucial to address. Aims: To create an up-to-date review of current knowledge on nightmares in BPD and to explore the links between nightmares, insomnia, and suicidality or self-harm in BPD patients. Method: This narrative review was conducted using the PubMed, Web of Science, and Google Scholar databases to search for articles published between January 1990 and October 2022, using the following key terms: 'borderline personality disorder' and 'nightmares' or 'insomnia' and 'suicidality' or 'self-harm' or 'self-injuring'. The final list consisted of 105 publications. Results: Sleep disturbances occur in BPD patients. The prevalence of nightmares in BPD is higher than in general or clinical populations. Nightmares influence borderline personality traits and vice versa through emotional dysregulation, poorer sleep quality, nightmare anxiety, higher arousal, and worsened self-control. A link between nightmares and suicidal behaviour was established in some psychiatric conditions (depression, insomnia); studies on BPD are lacking in this area. Studies comparing nightmares in BPD to other disorders are also missing. There are some suggestions for pharmaceuticals or psychotherapy in treating nightmares, but their application to BPD needs more research. Conclusion: Sleep disturbance and nightmares are common among individuals with BPD yet underrepresented in research. Nightmares have been linked with suicidality in other conditions (depression, PTSD) but only indirectly in BPD. More clinical studies are needed to explore the phenomenon further.
Article
Objective The suicide mortality rate among people suffering from cluster B personality disorders is estimated at approximately 20%. High occurrence of comorbid depression and anxiety, as well as substance abuse, are known contributors to this risk. Not only have recent studies indicated that insomnia may be a suicide risk factor, but it is also thought to be highly prevalent in this clinical group. However, the mechanisms explaining this association are still unknown. It has been suggested that emotion dysregulation and impulsivity may mediate the link between insomnia and suicide. In order to better understand the association between insomnia and suicide in cluster B personality disorders, it is important to consider the influence of comorbidities. The aims of this study were first to compare the levels of insomnia symptoms and impulsivity between a group of patients with cluster B personality disorder and a healthy control group and second, to measure the relationships between insomnia, impulsivity, anxiety, depression, substance abuse and suicide risk within the cluster B personality disorder sample. Methods Cross-sectional study including 138 patients (mean age = 33.74; 58.7% women) with cluster B personality disorder. Data from this group were extracted from a Quebec-based mental health institution database (Signature bank: www.banquesignature.ca) and were compared to that of 125 healthy subjects matched for age and sex, with no history of personality disorder. Patient diagnosis was determined by diagnostic interview upon admission to a psychiatric emergency service. Anxiety, depression, impulsivity and substance abuse were also assessed at that time point via self-administered questionnaires. Participants from the control group visited the Signature center to complete the questionnaires. A correlation matrix and multiple linear regression models were used to explore relations between variables. Results In general, more severe insomnia symptoms and higher levels of impulsivity distinguished the group of patients with cluster B personality from the sample of healthy subjects, although groups did not differ on total sleep time. When all variables were included as predictors in a linear regression model to estimate suicide risk, subjective sleep quality, lack of premeditation, positive urgency, depression level and substance use were significantly associated with higher scores on the Suicidal Questionnaire-Revised (SBQ-R). The model explained 46.7% of the variance of scores at the SBQ-R. Conclusion This study yields preliminary evidence indicating the possible implication of insomnia and impulsivity in suicide risk for individuals with cluster B personality disorder. It is proposed that this association seems to be independent of comorbidity and substance use levels. Future studies may shed light on the possible clinical relevance of addressing insomnia and impulsivity in this clinical population.
Article
Full-text available
Objectif Le taux de mortalité par suicide parmi les personnes souffrant d’un trouble de la personnalité du groupe B (TPB) se situe autour de 20 %. La haute prévalence de comorbidités anxiodépressives ainsi que l’abus de substances majorent ce risque. Selon des études récentes, l’insomnie persistante serait aussi un facteur de risque suicidaire dans ce groupe clinique. Les mécanismes expliquant cette association sont peu connus. Il a été proposé que des facteurs psychopathologiques comme la dysrégulation émotionnelle ou l’impulsivité pourraient agir comme médiateurs dans ce lien entre l’insomnie et le suicide. Afin de bien comprendre la relation insomnie-suicide dans le TPB, il est important d’identifier le rôle des comorbidités. L’étude comporte deux objectifs. Le premier vise à comparer la sévérité des symptômes d’insomnie et le niveau d’impulsivité d’un groupe avec TPB à ceux d’un groupe contrôle, le deuxième tente d’établir les relations entre l’insomnie, l’impulsivité, les comorbidités anxiodépressives, l’abus de substance et le risque suicidaire. Méthode Étude transversale portant sur 138 patients (âge moyen = 33,74 ; 58,7 % femmes) ayant un TPB. Les données de ce groupe, obtenues à partir d’une base de données d’un institut en santé mentale québécois (banque Signature : www.banquesignature.ca) ont été comparées à celles d’un groupe de 125 sujets sains appariés sur l’âge et le sexe et sans historique de trouble mental. C’est à l’admission aux urgences psychiatriques que le diagnostic de TPB a été déterminé à l’aide d’une entrevue diagnostique et que des questionnaires autorapportés mesurant l’anxiété, la dépression, l’impulsivité et l’abus de substances ont été remplis par les participants. Les participants du groupe contrôle se sont rendus au centre Signature afin de compléter ces mêmes questionnaires. Une matrice corrélationnelle et une régression linéaire multiple ont été utilisées pour explorer les relations entre les variables. Résultats Le groupe avec TPB présentait des symptômes d’insomnie plus élevés et des niveaux d’impulsivité supérieurs par rapport au groupe contrôle, à l’exception du temps total de sommeil. Dans le modèle de régression, la satisfaction envers le sommeil, le manque de préméditation, l’urgence positive, la dépression et l’utilisation de substances étaient significativement associés aux scores au Suicidal Behavior Questionnaire-Revised (SBQ-R). Ce modèle expliquait 46,7 % de la variance des scores au SBQ-R. Conclusion Les résultats ont permis de mettre en évidence, pour la première fois, les éléments d’insomnie et d’impulsivité qui distinguent un groupe avec TPB par rapport à un groupe contrôle sain. Cette étude indique que l’insomnie et l’impulsivité pourraient être des facteurs de risque suicidaire dans le TPB, indépendamment des comorbidités et de l’utilisation de substances. De futures études permettront de vérifier la pertinence clinique potentielle de ces éléments de risque pour cette patientèle.
Article
Short sleep duration has been linked to higher levels of aggression. To synthetize all available research on this association, a systematic review and meta-analysis was performed. We included observational and experimental studies, using various measures of sleep duration and aggression. Eighty eligible papers were identified, describing 82 studies comprising a total number of 76.761 participants. Meta-analysis of results was possible for 60 studies. Pooled observational results on the association between sleep duration and aggression showed a correlation estimate of −0.16 (95%CI -0.19, −0.12; I² = 83.9%) and an odds ratio estimate of 1.83 (95%CI 1.47, 2.28; I² = 0.0%). For experimental studies, the pooled Standardized Mean Difference after manipulation of sleep duration was −0.37 (95%CI -0.80, 0.05; I² = 89.05%) for controlled designs and −0.34 (95%CI -0.54, −0.14; I² = 89.05%) for pre-post designs. Effect estimates were stronger for individuals with psychological vulnerabilities and younger persons. Exclusion of studies with low methodological quality strengthened the effect estimate in experimental but not in observational studies. To conclude, short sleep duration is associated with higher levels of aggression, with observational research strongly supporting the association and experimental studies providing mixed results. More well-designed prospective and experimental studies are needed to establish causality and optimize treatment, especially for individuals with psychological vulnerabilities.
Article
Clinicians and theorists have argued that the depression characteristic of borderline patients is phenomenologically distinct from that of other unipolar depressives. In the present study, the quality of depressive experience was examined in borderline patients with (n=16) and without (n=17) major depression as compared with nonborderline major depressives (n=14). In support of the hypothesis, borderlines with and without major depression evidenced a qualitatively distinct, interpersonally focused 'borderline depression,' even controlling for severity of depression. Phenomenologically, this borderline depression is characterized by emptiness, loneliness, desperation in relation to attachment figures, and labile, diffuse negative affectivity.
Article
Background: No unbiased estimates of the rates of psychiatric disorder among women prison inmates are available. Nonetheless, available data suggest that some psychiatric disorders are prevalent in this population. The objective of the study was to determine the rates, risk factors, and outcomes of specific psychiatric disorders among women prison inmates. Methods: A virtual census of women felons (N=805) entering prison in North Carolina was assessed using in-person interviews. Assessments were conducted for 8 disorders, using the Composite International Diagnostic Interview as the primary assessment measure. For validation purposes, one quarter of the inmates were reassessed for 2 of these disorders, using structured clinical interviews. Results: Inmates were found to have high rates of substance abuse and dependence and antisocial and borderline personality disorders compared with women in community epidemiologic studies. Rates among inmates were also somewhat elevated for mood disorders but not for anxiety disorders. The rate of reports of lifetime exposure to traumatic events was also high. Rates of disorder tended to be higher among white than among African American women. Conclusion: High rates of substance abuse, psychiatric disorder, and psychological distress associated with exposure to traumatic events suggest that women in prison have a need for treatment for substance abuse and other mental health problems.
Article
We examined the association between psychopathy, assessed using the Hare Psychopathy Checklist-Revised (PCL-R—Hare, 1991), and substance use in a sample of 200 male federal prison inmates. Psychopathy diagnoses were not significantly comorbid with alcohol or drug use disorders. However, dimensional PCL-R scores were correlated with DSM-III-R diagnoses of drug abuse/dependence, the number of different drugs tried, age at first alcohol intoxication, and the number of drug-related charges and convictions. A meta-analysis of four studies looking at dimensional PCL-R scores and substance use revealed that the association was highly consistent across studies and moderate in magnitude for drug use disorders but somewhat inconsistent and weaker in magnitude for alcohol use disorders. Analyses using the PCL-R factors yielded results consistent with the suggestion that substance use is associated with an unstable, antisocial life-style rather than with the interpersonal and affective characteristics of psychopathy
Article
The essential linkage of sleep disturbance and clinical depression has long been recognized. Almost all patients with major depression report some form of sleep difficulty including insomnia, oversleeping, and poor-quality sleep. Some have argued that these changes in the sleep-wake cycle are actually aspects of a more fundamental alteration in circadian rhythms. Antidepressants that reduce restless sleep and awakenings and improve daytime alertness are desirable. It also appears that compounds that “rearrange” the intensity of rapid eye movement and slow-wave sleep may provide the best clinical effects on sleep besides antidepressant clinical efficacy. Agomelatine, a new antidepressant with melatonergic activity and 5-HT2c antagonist properties, has shown its efficacy in major depression. Beyond this antidepressant efficacy, agomelatine demonstrates sleep electroencephalographic changes consistent with desirable sleep architecture improvements, as well as improved subjective sleep quality within the first week of administration accompanied by an improvement in daytime alertness.
Article